Annick Lavoie

1.7k total citations
43 papers, 1.2k citations indexed

About

Annick Lavoie is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Speech and Hearing. According to data from OpenAlex, Annick Lavoie has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 5 papers in Speech and Hearing. Recurrent topics in Annick Lavoie's work include Cystic Fibrosis Research Advances (29 papers), Esophageal and GI Pathology (6 papers) and Respiratory Support and Mechanisms (5 papers). Annick Lavoie is often cited by papers focused on Cystic Fibrosis Research Advances (29 papers), Esophageal and GI Pathology (6 papers) and Respiratory Support and Mechanisms (5 papers). Annick Lavoie collaborates with scholars based in Canada, United States and France. Annick Lavoie's co-authors include Anne S. Pohlman, Päivi Valta, J. Milic‐Emili, J. Braidy, Νikolaos Koulouris, C. Corbeil, Rémi Rabasa‐Lhoret, Sangeeta Bhorade, Michael O’Connor and Yves Berthiaume and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Annick Lavoie

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annick Lavoie Canada 15 939 245 171 166 128 43 1.2k
Päivi Valta Finland 14 888 0.9× 247 1.0× 145 0.8× 66 0.4× 160 1.3× 24 1.3k
Himanshu Desai United States 11 281 0.3× 268 1.1× 233 1.4× 151 0.9× 284 2.2× 16 906
Dominic Cave Canada 17 233 0.2× 138 0.6× 257 1.5× 105 0.6× 123 1.0× 34 797
Meme Wijesinghe New Zealand 20 804 0.9× 391 1.6× 86 0.5× 142 0.9× 65 0.5× 28 1.2k
Eliezer Nussbaum United States 20 741 0.8× 315 1.3× 127 0.7× 47 0.3× 41 0.3× 70 1.3k
P. Frascarolo Switzerland 14 510 0.5× 296 1.2× 267 1.6× 167 1.0× 96 0.8× 22 1.1k
George Baltopoulos Greece 16 265 0.3× 148 0.6× 183 1.1× 114 0.7× 155 1.2× 47 951
Gilles Dumoulin France 23 347 0.4× 229 0.9× 138 0.8× 187 1.1× 223 1.7× 59 1.5k
Katsuyuki Miyasaka Japan 17 694 0.7× 60 0.2× 297 1.7× 119 0.7× 178 1.4× 56 1.1k
Sheldon R. Braun United States 20 671 0.7× 351 1.4× 199 1.2× 122 0.7× 40 0.3× 46 1.1k

Countries citing papers authored by Annick Lavoie

Since Specialization
Citations

This map shows the geographic impact of Annick Lavoie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Lavoie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Lavoie more than expected).

Fields of papers citing papers by Annick Lavoie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Lavoie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Lavoie. The network helps show where Annick Lavoie may publish in the future.

Co-authorship network of co-authors of Annick Lavoie

This figure shows the co-authorship network connecting the top 25 collaborators of Annick Lavoie. A scholar is included among the top collaborators of Annick Lavoie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick Lavoie. Annick Lavoie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Boudreau, Valérie, et al.. (2024). Feasibility and accuracy of at-home glucose tolerance tests for cystic fibrosis related diabetes screening. Journal of Cystic Fibrosis. 23(5). 857–862.
3.
Waters, Valerie, Michelle Shaw, Lucy Perrem, et al.. (2024). A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment. European Respiratory Journal. 63(6). 2302278–2302278. 5 indexed citations
4.
Potter, Kathryn J., Adèle Coriati, François Tremblay, et al.. (2024). Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance. Diabetes Obesity and Metabolism. 26(10). 4744–4752. 1 indexed citations
5.
Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2022). Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes. Journal of Cystic Fibrosis. 22(1). 50–58. 11 indexed citations
6.
Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2022). Marginal association of fasting blood glucose with the risk of cystic fibrosis-related diabetes. Annales d Endocrinologie. 84(2). 265–271. 3 indexed citations
7.
Potter, Kathryn J., Valérie Boudreau, Katherine Desjardins, et al.. (2021). Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis. Diabetologia. 64(6). 1332–1341. 18 indexed citations
8.
Potter, Kathryn J., Quitterie Reynaud, Valérie Boudreau, et al.. (2021). Prevalence of Post–Glucose Challenge Hypoglycemia in Adult Patients With Cystic Fibrosis and Relevance to the Risk of Cystic Fibrosis–Related Diabetes. Canadian Journal of Diabetes. 46(3). 294–301.e2. 1 indexed citations
9.
Potter, Kathryn J., Valérie Boudreau, Azadeh Shohoudi, et al.. (2021). Influence of pre-diabetic and pancreatic exocrine states on pulmonary and nutritional status in adults with Cystic Fibrosis. Journal of Cystic Fibrosis. 20(5). 803–809. 18 indexed citations
10.
11.
Boudreau, Valérie, François Tremblay, Annick Lavoie, et al.. (2017). Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia. Journal of Cystic Fibrosis. 16(3). 418–424. 13 indexed citations
12.
Lavoie, Annick, et al.. (2016). Points de vue d'acteurs scolaires et d'intervenants communautaires sur les besoins d'éléves immigrants et de leur famille dans des écoles défavorisées á Montréal. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Lavoie, Annick, et al.. (2016). Ralstonia mannitolilytica in cystic fibrosis: A new predictor of worse outcomes. Respiratory Medicine Case Reports. 20. 48–50. 23 indexed citations
14.
Lavoie, Annick, et al.. (2012). Pericardial Fat Necrosis Presenting as Acute Pleuritic Chest Pain. Journal of Emergency Medicine. 44(2). e269–e271. 8 indexed citations
15.
Aaron, Shawn D., Katherine L. Vandemheen, Andreas Freitag, et al.. (2012). Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study. PLoS ONE. 7(4). e36077–e36077. 62 indexed citations
16.
Berthiaume, Yves, Alphonse Jeanneret, Annick Lavoie, et al.. (2007). Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. Journal of Cystic Fibrosis. 6(6). 376–383. 66 indexed citations
17.
Lavoie, Annick, et al.. (2000). The Incidence and Pathogenesis of Cardiopulmonary Deterioration after Abrupt Withdrawal of Inhaled Nitric Oxide. American Journal of Respiratory and Critical Care Medicine. 161(5). 1443–1449. 73 indexed citations
18.
Bhorade, Sangeeta, et al.. (1999). Response to Inhaled Nitric Oxide in Patients with Acute Right Heart Syndrome. American Journal of Respiratory and Critical Care Medicine. 159(2). 571–579. 112 indexed citations
19.
Lavoie, Annick, et al.. (1996). Life-Threatening Effects of Discontinuing Inhaled Nitric Oxide in Severe Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 153(6). 1985–1987. 105 indexed citations
20.
Valta, Päivi, C. Corbeil, Annick Lavoie, et al.. (1994). Detection of Expiratory Flow Limitation During Mechanical Ventilation. American Journal of Respiratory and Critical Care Medicine. 150(5). 1311–1317. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Päivi Valta Breakdown of academic impact, for papers by Himanshu Desai Breakdown of academic impact, for papers by Dominic Cave Breakdown of academic impact, for papers by Meme Wijesinghe Breakdown of academic impact, for papers by Eliezer Nussbaum Breakdown of academic impact, for papers by P. Frascarolo Breakdown of academic impact, for papers by George Baltopoulos Breakdown of academic impact, for papers by Gilles Dumoulin Breakdown of academic impact, for papers by Katsuyuki Miyasaka Breakdown of academic impact, for papers by Sheldon R. Braun
Rankless by CCL
2026